SpeeDx Receives CE-IVD Mark for PlexPCR® SARS-CoV-2
on April 26 2021 5:00 PM
New robust design COVID-19 test performs well against all known virus variants while supporting surging demand for reliable tests
SYDNEY (BUSINESS WIRE) #COVID19 SpeeDx Pty. Ltd. announced today it has received CE-IVD marking for its
Plex
PCR
® SARS-CoV-2 assay – a two gene test for the detection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative agent of COVID-19. The high-throughput test is compatible with 96- or 384-well qPCR systems and liquid handling robotics to support a streamlined laboratory workflow and accelerate time to result.
“The COVID-19 pandemic has impacted testing laboratories throughout the world as many diagnostic supply companies have struggled to meet testing needs,” said SpeeDx CEO Colin Denver. “This has disrupted supply chains and impacted efficiency across the board. SpeeDx has the advantage of not needing to manufacture target-specif
SpeeDx Receives CE-IVD Mark for PlexPCR SARS-CoV-2
financialbuzz.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from financialbuzz.com Daily Mail and Mail on Sunday newspapers.
SpeeDx Increase Distribution Network
apnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from apnews.com Daily Mail and Mail on Sunday newspapers.